ClinicalTrials.govpublic full text
Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH
non-alcoholic fatty liver disease, gsk4532990, non-alcoholic steatohepatitis (nash), non-alcoholic fatty liver disease (nafld), suspected nash, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 903008
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.